Moreover, kynurenine aminotransferase 2 (KAT2), which convert kynurenine into kynurenic acid (KYNA), was manifested with higher expression level in cluster 1, suggesting protective effects of KYNA in glioma. The gene discussed is AADAT; the disease is glioma.